Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.7288
-0.0241 (-3.20%)
Mar 31, 2025, 2:27 PM EDT - Market open

Vor Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Selling, General & Admin
27.8831.7228.8721.4911.75
Upgrade
Research & Development
93.3194.3264.5547.5331.62
Upgrade
Operating Expenses
121.19126.0493.4269.0243.37
Upgrade
Operating Income
-121.19-126.04-93.42-69.02-43.37
Upgrade
Interest & Investment Income
4.278.171.320.120.03
Upgrade
Pretax Income
-116.91-117.86-92.09-68.9-43.34
Upgrade
Net Income
-116.91-117.86-92.09-68.9-43.34
Upgrade
Preferred Dividends & Other Adjustments
---1.235.93
Upgrade
Net Income to Common
-116.91-117.86-92.09-70.13-49.26
Upgrade
Shares Outstanding (Basic)
696740330
Upgrade
Shares Outstanding (Diluted)
696740330
Upgrade
Shares Change (YoY)
2.25%69.88%18.30%15548.01%85.85%
Upgrade
EPS (Basic)
-1.70-1.75-2.33-2.10-230.56
Upgrade
EPS (Diluted)
-1.70-1.75-2.33-2.10-230.56
Upgrade
Free Cash Flow
-99.89-101.36-93.61-73.04-40.45
Upgrade
Free Cash Flow Per Share
-1.45-1.51-2.37-2.19-189.34
Upgrade
EBITDA
-117.66-122.54-90.89-67.58-42.76
Upgrade
D&A For EBITDA
3.533.492.531.430.61
Upgrade
EBIT
-121.19-126.04-93.42-69.02-43.37
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q